IOVS Annual Reviews: Social Science Suite
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1167/iovs.07-1299 on April 4, 2008
 (Investigative Ophthalmology and Visual Science. 2008;49:3185-3192.)
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.07-1299
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
iovs.07-1299v1
49/7/3185    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, Y.
Right arrow Articles by Ma, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, Y.
Right arrow Articles by Ma, Z.

Autologous Transplantation of RPE with Partial-Thickness Choroid after Mechanical Debridement of Bruch Membrane in the Rabbit

Yuntao Hu,1 Taoran Zhang,1 Jianguo Wu,1 Ying Li,1 Xinrong Lu,1 Fang Qian,1 Zhengqin Yin,2 and Zhizhong Ma1

1From the Peking University Eye Center, Peking University Third Hospital, Beijing, China; and the 2Southwest Eye Hospital, Third Military Medical University, Chongqing, China.


   Abstract
Top
 Abstract
Materials and Methods
 Results
 Discussion
 References
 
PURPOSE. An improved translocation technique for autologous retinal pigment epithelium (RPE) transplantation is presented. The graft consists of a sheet of a partial-thickness choroid with RPE attached.

METHODS. Twenty-seven pigmented rabbits were used in this study. After mechanical debridement of Bruch membrane, partial-thickness RPE-choroid sheets were transplanted onto the subretinal space in 25 rabbits. The animals were examined by fundus photographs and fluorescein angiographs and were killed postoperatively at 1, 2, 4, 12, and 24 weeks. Eyecups containing the grafts were examined by light microscopy and immunohistochemistry. In addition, two partial-thickness RPE-choroid sheets were analyzed by transmission electron microscopy (TEM).

RESULTS. TEM revealed that the partial-thickness RPE-choroid graft consisted of retinal pigment epithelial cells, Bruch membrane, choriocapillaris, and ruptured middle vessels. The thickness of the graft was approximately 50 to 60 µm. Fluorescein angiography revealed neither fluorescein leakage nor staining in the graft at early or late phase. Light microscopy revealed that in 17 experiments in which the graft survived, the neural retina remained intact; however, in eight experiments with unsuccessful grafts, the neural retina degenerated. The surviving graft showed revascularization and monolayered retinal pigment epithelial cells. Furthermore, in sections in which the neural retina over the graft remained intact, all retinal pigment epithelial cells in the graft and rhodopsin in photoreceptor outer segments were positively labeled with anticellular retinaldehyde-binding protein antibodies and anti-opsin antibodies, respectively.

CONCLUSIONS. A partial-thickness RPE-choroid graft showed improved integration with the host choroid and photoreceptors. This technique has the potential to be a treatment for age-related macular degeneration.

Although photocoagulation, photodynamic therapy, and antichoroidal neovascularization (CNV) therapy (pegaptanib sodium, bevacizumab, and ranibizumab) can be used to treat the exudative form of age-related macular degeneration (AMD),1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 surgical excision of subfoveal choroidal neovascular membranes is necessary when AMD develops to a certain pathologic state. Submacular surgery has shown disappointing results because of the loss of the retinal pigment epithelium (RPE) concurrent with the removal of the neovascular membrane.18 19 20 21 22 23

Various attempts have been made to overcome this problem. Macular translocation appears to improve visual acuity.24 25 26 27 28 However, full or limited macular translocation bears considerable risk for proliferative vitreoretinopathy, retina detachment, ocular torsion and diplopia, intraocular hemorrhage, and macular fold.29 30 31 32 33 34 The iris pigment epithelium (IPE) is easily accessible; however, it does not have all the functions of the RPE.35 36 37 38 Multilayers of IPE cells implanted onto the subretinal space may induce adverse focal effects on adjacent photoreceptors.39 Heterologous RPE transplantation to substitute for the loss of RPE is not feasible because of host-graft rejection.40 41 42 43 44 Therefore, autologous RPE transplantation was developed.

A method for autologous RPE transplantation is application of a suspension of cells.45 46 47 48 In this method, it is difficult to control the amount of retinal pigment epithelial cells and to induce the cells to form a monolayer on Bruch membrane. Another method is translocation of an autologous sheet of full-thickness RPE-choroid, belonging to the extramacular area, to the submacular space after the removal of CNV. The graft consists of RPE, Bruch membrane, choriocapillaris, and choroid. Some investigators have demonstrated the clinical feasibility of this technique49 50 51 52 53 54 55 56 ; however, MacLaren57 reported that the long-term results were not positive. Yepez et al.58 performed autologous RPE-choroid complex transplantation in five AMD patients by using a similar procedure. They found that subretinal fibrosis developed in all five patients and that graft pigmentation was lost between 30 and 60 days after the procedure. No significant improvement in visual acuity was observed in any of these patients. The authors believed that an autologous-free RPE-choroid graft is destined to fail.58 We speculate that the graft might be very thick, thereby preventing the transport of nutrients from the choroid to the RPE. If the thickness of the sheet of the RPE-choroid complex is reduced, the graft may survive more easily.

Removing part of the choroidal tissue could make the graft thinner; this was termed partial-thickness RPE-choroid sheet. In the present study, we report the histologic outcomes of autologous transplantation of partial-thickness RPE-choroid sheet after abrasive debridement of Bruch membrane in rabbit models.


   Materials and Methods
Top
 Abstract
 Materials and Methods
Results
 Discussion
 References
 
Animals and Anesthesia
Twenty-seven pigmented rabbits, each weighing 2 to 2.5 kg, were used for this study. All surgical procedures were performed in one eye of each animal. The rabbits were anesthetized by intramuscular injection of a mixture of ketamine hydrochloride (15 mg/kg) and xylazine hydrochloride (15 mg/kg). Local anesthesia was applied to the experimental eye by a subconjunctival injection of 2% lidocaine hydrochloride (0.5 mL). The pupils were dilated with topical 1% tropicamide and 2.5% phenylephrine hydrochloride. All animals were cared for in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.

Surgery
After anesthesia and pupil dilation, a sterile field was established around the experimental eye. A 360° conjunctival peritomy was performed. The lens was extracted by phacoemulsification through a 1.5-mm incision on the superior corneal limbus. The posterior capsular was preserved, and the incision of the limbus was closed. Next, an infusion cannula was inserted through the inferior nasal sclerotomy site, which was located 2 mm posterior to the limbus, and balanced salt solution (BSS) plus was used as an irrigating solution; standard three-port vitrectomy, including a posterior hyaloid detachment, was performed using a pneumatic cutter (Storz, St. Louis, MO) through the contact lens under a surgical microscope.

To prepare the graft, a donor area of approximately 2-optic disc (OD) diameters and located at 1.5-OD diameters inferior to the OD was treated by diathermy coagulation. The retina was removed, and the RPE in this area was exposed. One side of this RPE-choroid area was cut with a 20-gauge knife. Subsequently, a sharp spatula was inserted into the choroid to split the choroidal vascular tissues, and these tissues were removed by a subretinal forceps. The partial-thickness RPE-choroid complex appeared semitransparent. A sheet of 1- to 1.5-OD diameter of partial-thickness RPE-choroid graft was obtained after the other sides were cut using a vitreous scissor (Fig. 1) .


Figure 1
View larger version (44K):
[in this window]
[in a new window]

  		FIGURE 1. Partial-thickness RPE-choroid sheet (arrow) was obtained with a vitreous scissor.

 
In the same experimental eye, the area superior to the OD was selected as the recipient bed. A localized retinal detachment was created by subretinal injection of BSS through a 30-gauge metal cannula, and the retinotomy site was enlarged to enable the implantation of the graft. At the recipient bed, the RPE from a 1.5-OD diameter area of Bruch membrane was carefully debrided with the use of a silicon cannula, and the shed retinal pigment epithelial cells were carefully removed using a vitreous cutter. Mild blanching of the choroidal vasculature was observed as the tip of the silicon cannula moved across the RPE-Bruch membrane surface; however, no choroidal bleeding occurred. Care was taken to avoid debridement directly under the retinotomy site.

After the recipient bed of Bruch membrane was prepared, the partial-thickness RPE-choroid graft was translocated to the area of denuded Bruch membrane by using a retinal forceps. The retina was repositioned and refixated by an air-fluid exchange, resulting in the enclosure of the graft within the retina. To complete the surgery, air was exchanged with silicone oil (5700 mPas viscosity; Bausch & Lomb, Waterford, Ireland). The area from which the partial-thickness RPE-choroid graft was obtained exposed the internal surface of sclera.

Finally, the sclerotomy sites were closed, and the conjunctiva was sutured. Dexamethasone (2.5 mg) and gentamicin (20 mg) were injected subconjunctivally, and the eye was dressed with erythromycin and 1% atropine ointment. After surgery, topical antibiotic and steroid were applied for 3 days.

Using the same surgical procedures, two partial-thickness RPE-choroid sheets were obtained from two rabbits (one sheet from one rabbit) without transplantation and subjected to morphologic examination by transmission electron microscopy (TEM).

Fundus Photography and Fluorescein Angiography
Color fundus photographs and fluorescein angiograms were obtained with a fundus camera (FF450 plus IR; Zeiss, Jena, Germany) at postoperative weeks 1, 2, 4, 12, and 24. Fluorescein angiography (FA) was performed by injecting 0.2 mL sodium fluorescein solution (10%) into the ear vein.

Histology
At postoperative weeks 1, 2, 4, 12, and 24, five experimental animals were sedated and killed, each by an intravascular overdose of 2% lidocaine. After death, each experimental eye was rapidly enucleated, punctured at the limbus, and immersed in 2.5% glutaraldehyde and 4% paraformaldehyde in a phosphate-buffer solution. After 2 hours, the anterior segment and intraocular silicon oil were removed. Subsequently, the posterior cup was fixed in the same solution for 48 hours.

To study each graft, the posterior cup was washed in 0.1 M phosphate-buffered saline (PBS) solution for 2 hours with three replacements. The tissue was then dehydrated in ascending ethanol concentrations. After dehydration, the tissue was cleared in xylene for 45 minutes and immersed in liquid paraffin for 1.5 hours at 60°C with three replacements. Subsequently, the area of the graft was cut as a small block of tissue, including the retina and sclera, embedded in paraffin wax, and processed for sectioning (5-µm sections). Groups of consecutive slides were stained with hematoxylin and eosin (HE) for light microscopy. If the neural retina over the graft was intact, its adjacent sections were treated for antigen retrieval and processed with immunolabeling of antibody against cellular retinaldehyde-binding protein (CRALBP; anti-CRALBP antibody, a gift from John C. Saari, University of Washington, Seattle, WA) and antibody against rhodopsin (monoclonal anti-opsin antibody O4886; Sigma-Aldrich, St. Louis, MO).

For the examination of the constituents of the graft, two sheets of partial-thickness RPE-choroid graft were immobilized on a nitrocellulose filter membrane (Hybond, Escondido, CA). The sheets were fixed in 2.5% glutaraldehyde at 4°C for 24 hours, postfixed with 1% osmium tetroxide at room temperature for 2 hours, and bloc stained and embedded in epoxy resin after dehydration in a graded acetone series. Semithin sections were stained with toluidine blue and observed under a light microscope. Ultrathin sections were stained with uranyl acetate and lead citrate and observed under an electron microscope (JEM1230; JEOL Inc., Tokyo, Japan).

Immunohistochemistry
Immunohistochemistry was performed as follows. Sections were dewaxed and rehydrated in descending ethanol to water. The slides were incubated in 3% hydrogen peroxide for 15 minutes to quench endogenous peroxidase activity. Antigenicity was increased by incubating the sections in 0.125% trypsin (Zymed-Invitrogen, South San Francisco, CA) for 30 minutes at room temperature. To detect CRALBP, the pigment of the tissues was bleached by incubating the sections in 0.75% potassium permanganate for 5 minutes, followed by incubation in 2% oxalic acid for 30 seconds (this procedure was not used in the detection of rhodopsin). Nonspecific binding sites were blocked by incubating the sections in 5% bovine serum albumin (Roche, Basel, Switzerland), and the sections were then incubated with primary antibodies (rabbit anti-CRALBP, 1:4000 dilution; mouse anti-opsin antibody, 1:2500 dilution) overnight at 4°C in a humidity chamber. No primary antibodies were used in negative controls. The signal was amplified by incubating the sections with secondary antibodies for 45 minutes at 37°C; anti-rabbit IgG-polymer-horseradish peroxidase (HRP; Polink-1 HRP Rb Bulk kit, D13–110; GBI, Mukilteo, WA) labeling for CRALBP and anti-mouse IgG-polymer-HRP (Polink-1 HRP Ms. Bulk kit, D12–110; GBI) labeling for rhodopsin. For color development, the sections were incubated with diaminobenzidine substrate for 5 to 10 seconds and counterstained with hematoxylin.


   Results
Top
 Abstract
 Materials and Methods
 Results
Discussion
 References
 
Complications of Surgery
After excision of a sheet of partial-thickness RPE-choroid, the sheet shrank by one third because of tissue contraction. However, the graft did not fold. In all procedures, primarily the following complications occurred: choroidal hemorrhage, choroidal detachment, and retinal pigment epithelial damage. Choroidal hemorrhage can be avoided by careful diathermy coagulation. Choroidal detachment was induced by mechanical intervention when a spatula was used to split the choroidal tissues. However, the choroid was always reattached after air-fluid exchange and was retained in situ after surgery. RPE and Bruch membrane might be torn by the spatula when the choroidal tissues were separated.

After surgery, all rabbits showed exudation in the anterior chamber within 3 days. The exudation was subsequently absorbed without any special treatment. Proliferative vitreoretinopathy (or retina detachment) and hemorrhage were not observed. One rabbit had a corneal ulcer within a few days of surgery. The cornea of this rabbit became opaque after the ulcer was cured, which hindered observation of the fundus. Thus, fundus photography and FA could not be performed on this rabbit.

Fundus Photography and FA
Fundus photographs revealed that all grafts were localized at the site of retinal pigment epithelial debridement, except for one graft that was observed outside the area of retinal pigment epithelial debridement. Neither retinal detachment nor hemorrhage was observed. As healing occurred, the grafts became flat, expanded slightly, and began to attach more firmly. Graft color was darker than that of the surrounding area. None of the grafts showed loss of pigment, significant shrinkage, or development of fibrosis.

In all grafts, from 1 week to 24 weeks after surgery, FA did not reveal fluorescein leakage or staining in the graft at early or late phase. Moreover, no window defect was observed in the grafts. However, FA revealed a window defect at the debridement site of Bruch membrane without graft covering (Fig. 2) .


Figure 2
View larger version (84K):
[in this window]
[in a new window]

  		FIGURE 2. At postoperative week 2, fundus photograph (A) showed the graft to be flat, and fluorescein angiography (B) showed no fluorescein leakage or staining in the graft. At postoperative week 24, fundus photography (C) showed the graft to be flat and semitransparent, and fluorescein angiography (D) showed no fluorescein leakage or staining in the graft; however, punctiform defects were observed at some points.

 
Histology and Immunohistochemistry
TEM showed that the 50- to 60-µm partial-thickness RPE-choroid graft consisted of retinal pigment epithelial cells, Bruch membrane, choriocapillaris, and ruptured middle vessels (Fig. 3) . The microvilli of retinal pigment epithelial cells were fractured; however, retinal pigment epithelial cells, Bruch membrane, and capillaries were intact.


Figure 3
View larger version (205K):
[in this window]
[in a new window]

  		FIGURE 3. TEM showed that the partial-thickness RPE-choroid graft consisted of retinal pigment epithelial cells, Bruch membrane, choriocapillaris (CC), and ruptured middle vessels (MV).

 
After implantation of the partial-thickness autologous RPE-choroid graft onto the subretinal space, light microscopy revealed two different outcomes for the neural retina over the graft. In successful grafts (17 eyes), the neural retina was almost intact. In these eyes, the retinal outer and inner nuclear layers, along with the ganglion cell layer, appeared normal, and, in some cases, photoreceptor outer segments were attenuated or shortened. The graft showed revascularization, and retinal pigment epithelial cells formed a monolayer. Inflammatory cells were not observed (Figs. 4A 4B) . In unsuccessful grafts (eight eyes), photoreceptor outer and inner segments disappeared, and the outer and inner nuclear layers became thinner or disappeared despite the graft vessels showing no obstructions and the graft retinal pigment epithelial cells appearing as a monolayer (Figs. 4C 4D) . These phenomena were observed postoperatively from 1 week to 24 weeks. Changes in the recipient Bruch membrane underneath the graft, which were examined by TEM, will be reported in another study.


Figure 4
View larger version (119K):
[in this window]
[in a new window]

  		FIGURE 4. Light microscopy showing partial-thickness RPE-choroid autologous graft (arrow) implanted onto the subretinal space that survived after 2 weeks (A) and 24 weeks (B). The graft showed revascularization, and the neural retina over the graft was almost intact. The partial-thickness RPE-choroid autologous grafts (arrow) that did not survive after 1 week (C) and 24 weeks (D) showed revascularization; however, the neural retina over the graft lost photoreceptor outer and inner segments. The outer nuclear layers almost disappeared at postoperative week 1, whereas all the inner and outer nuclear layers disappeared at postoperative week 24. (Hematoxylin-eosin staining.)

 
In sections in which the neural retina over the graft was intact, all retinal pigment epithelial cells of the graft and rhodopsin in photoreceptor outer segments over the graft were positively labeled with anti-CRALBP antibodies and anti-opsin antibodies, respectively. No significant difference was observed in these sections at each time period after surgery. Furthermore, sections without the application of primary antibodies showed negative results for antibody labeling (Figs. 5A 5B 5C 5D) .


Figure 5
View larger version (115K):
[in this window]
[in a new window]

  		FIGURE 5. At postoperative week 24, in the graft that survived, rhodopsin in photoreceptor outer segments (A, arrow) and all retinal pigment epithelial cells (B, arrow) were positively labeled with anti-opsin antibodies and anti-CRALBP antibodies, respectively. Sections without the application of primary antibodies showed negative results (C, D). To eliminate the interference of pigment granules in the retinal pigment epithelial cells for detecting CRALBP, the tissues were bleached in the sections (B, D); however, this procedure was not used in the detection of rhodopsin (A, C).

 

   Discussion
Top
 Abstract
 Materials and Methods
 Results
 Discussion
References
 
The RPE is a monolayer cuboidal epithelium located between the retinal photoreceptors and the choroid. Many techniques have been developed for transplantation of a sheet of RPE. These techniques include culturing retinal pigment epithelial cells on an amniotic membrane, Descemet membrane, or anterior lens capsule,59 60 61 62 63 using synthetic biodegradable substrate as a support material,64 65 66 sandwiching a retinal pigment epithelial sheet between two sheets of gelatin for transplantation,67 and excising a peripheral patch of autologous full-thickness RPE-choroid and translocation to the submacular space.49 50 51 52 53 54 55 56

It is obvious that the technique of using an autologous retinal pigment epithelial sheet can minimize the risk for host-graft rejection and can reduce ethical or religious conflicts arising from transplants and the use of human fetal retinal pigment epithelial cells or cadaveric donors. Therefore, autologous retinal pigment epithelial sheet as a transplant is the optimal option for retinal pigment epithelial transplantation to the submacular space after CNV excision in AMD. This approach was first suggested by Payman et al.49 Several investigators have reported the transplantation of a patch of autologous full-thickness RPE-choroid in the surgical treatment of AMD.50 51 52 53 54 55 56 57 58 However, in some cases, the results were disappointing, and the transplants developed subretinal fibrosis.51 57 58 In the study by Maaijwee et al.,68 although the full-thickness RPE-choroid graft showed revascularization in histologic examination, the neural retina did not remain intact after graft transplantation in pig models. We speculated that these grafts might not survive because of their thickness. Similarly, in skin transplantation, partial-thickness graft survives more easily than full-thickness graft.69 If the thickness of an RPE-choroid sheet is reduced by removing part of the choroidal tissues, the graft (termed partial-thickness RPE-choroid graft) would become thinner and survive more easily while allowing easy diffusion of nutrients from the choroid to the RPE and photoreceptors. Using the same assumption, Holz70 suggested intraocular microablation of the choroidal tissue by 308-nm laser energy (AIDA Excimer Laser System; TuiLaser AG, Germering, Germany) for retinal pigment epithelial transplantation.

In our study, partial-thickness RPE-choroid was prepared with an intraocular sharp spatula by removing part of the choroidal tissues. All the surgical manipulations were thoroughly performed in the same eye. The grafts did not fold. After surgery, the grafts became flatter and appeared semitransparent; this showed that the grafts had grown together with the recipient bed by attaching more firmly to the bed. FA revealed that the grafts functioned as a barrier to both the passage of dye and the emission of fluorescence.

The finding that the RPE of the recipient bed was intentionally damaged by our technique was similar to that reported in the study by Maaijwee et al.68 Histologic examination revealed that the survived graft showed not only revascularization but also intact neural retina. This result was different from that reported in the study by Maaijwee et al.68 and demonstrated that the partial-thickness RPE-choroid graft performs a normal function of supporting the neural retina, even though the rabbit retina has no vascular supply except for a narrow horizontal band of medullated nerve fibers and is nourished by nutrients obtained from the choroid. If the graft shows only revascularization but a degenerated neural retina, we cannot affirm that the graft is successful because it does not perform its function of supporting the neural retina. Our experimental results revealed that the partial-thickness RPE-choroid sheet could support the neural retina.

Immunohistochemical examination revealed that in successful grafts, CRALBP in retinal pigment epithelial cells in the graft and rhodopsin in photoreceptors were positively labeled with the corresponding antibodies. CRALBP, a protein thought to participate in retinoid metabolism and visual pigment regeneration,71 72 is present in both the neural retina and the RPE.73 CRALBP was used previously as a marker for retinal pigment epithelial differentiation.67 74 Rhodopsin is present within internal membrane structures, known as disc membranes, found in the rod outer segments of photoreceptors in the retina. Rhodopsin is responsible for light trapping and optical signal transduction for photoreceptors.75 76 77 78 79 80 Retinal pigment epithelial cell damage affects the chromophore retinaldehyde-binding opsin, resulting in distortion of rhodopsin in the photoreceptors.81 Therefore, rhodopsin is an important cell marker for experimental studies on retinal transplantation.82 83 Because approximately 95% of the photoreceptors in the rabbit retina are rods,84 we selected rhodopsin as the cell marker to assess the results of retinal pigment epithelial transplantation.

In unsuccessful transplants, the neural retina over the graft was significantly damaged. It was concluded that the neural retina underwent necrosis, even if some grafts showed revascularization.

Why did some grafts fail to survive?

1. We did not use perfluorodecalin to reattach the retina during the surgery. After air-fluid exchange, a small amount of fluid sometimes remained in the subretinal space because the retinotomy site was located at a superior position. Therefore, the graft that was transplanted onto the subretinal space could not tightly adhere to Bruch membrane and obtain sufficient nutrients from the recipient bed.

2. The thickness of the graft might have influenced its survival rate given that some grafts were thicker because of technique. We speculated that the thicker the autologous-free RPE-choroid graft, the more difficult the reestablishment of blood circulation with local choroidal vessels and diffusion of nutrients from the choroid to the RPE and photoreceptors.

3. The blood supply of the choroidal recipient bed might have influenced the graft survival rate. It has been proven that choriocapillary atrophy and reduction in the flow through the choroidal vessels occur after RPE removal.85 86 87 In the present study, Bruch membrane was debrided at the recipient bed to mimic the damage after CNV extraction in AMD patients. If the local choroidal vessels had no perfusion, even if it was reversible, it would not be beneficial to the autologous-free graft survival. If the autologous-free graft does not receive nutrients rapidly from the recipient bed vessels, it will die or undergo necrosis within a short duration. On the other hand, a diffusion defect of the choriocapillaris and a decrease in the size of large choroidal vessels at the macular region are known to occur in AMD patients.88 89 90 91 92 Thus, this technique of autologous retinal pigment epithelial transplantation must be further evaluated in experimental and clinical research.

In conclusion, the present study demonstrates the feasibility and histologic outcomes of autologous transplantation of partial-thickness RPE-choroid sheet. The graft not only survived but also performed its normal function, as demonstrated by graft revascularization and intact neural retina over the graft, respectively. This technique may be feasible for the surgical treatment of AMD.


   Acknowledgements
 
The authors thank John C. Saari for his generous support, Jianghong Zheng and Baozong Han for making special surgical tools, Baihe Hu and Xin Chang for assistance in transmission electron microscopy, Guohua Lu for carefully nursing the experimental animals, and Wei Wang and Pei Zhang for instruction in histopathologic technique.


   Footnotes
 
Supported by Peking University Third Hospital Clinical Research Grant and National Basic Research Program of China (2007CB512203).

Submitted for publication October 7, 2007; revised January 16, February 21, and March 14, 2008; accepted May 12, 2008.

Disclosure: Y. Hu, None; T. Zhang, None; J. Wu, None; Y. Li, None; X. Lu, None; F. Qian, None; Z. Yin, None; Z. Ma, None

The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Corresponding author: Zhizhong Ma, Peking University Eye Center, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100083, China; puh3_yk{at}bjmu.edu.cn.


   References
Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

  1. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991;109(9)1220–1231.[Abstract/Free Full Text]
  2. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991;109(9)1232–1241.[Abstract/Free Full Text]
  3. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration: guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol. 1991;109(9)1242–1257.[Abstract/Free Full Text]
  4. Coscas G, Soubrane G, Ramahefasolo C, Fardeau C. Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991;109(9)1258–1265.[Abstract/Free Full Text]
  5. Rechtman E, Ciulla TA, Criswell MH, Pollack A, Harris A. An update on photodynamic therapy in age-related macular degeneration. Expert Opin Pharmacother. 2002;3(7)931–938.[CrossRef][Medline][Order article via Infotrieve]
  6. Harding S. Photodynamic therapy in the treatment of subfoveal choroidal neovascularisation. Eye. 2001;15(pt 3)407–412.[Web of Science][Medline][Order article via Infotrieve]
  7. Wygnanski-Jaffe T, Desatnik H, Alhalel A, et al. ICG angiography-guided photodynamic therapy for large pigment epithelial detachments in age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2006;37(5)358–363.[Web of Science][Medline][Order article via Infotrieve]
  8. Fraunfelder FW. Pegaptanib for wet macular degeneration. Drugs Today. 2005;41(11)703–709.[CrossRef][Medline][Order article via Infotrieve]
  9. Konderding MA. Ocular angiogenesis: translating preclinical indications to successful clinical development. Expert Opin Ther Targets. 2004;8(3)255–258.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  10. Ng EWM, Adamis AP. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol. 2005;40(3)352–368.[Web of Science][Medline][Order article via Infotrieve]
  11. Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology. 2005;112(6)1035–1047.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  12. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005;36(4)331–335.[Web of Science][Medline][Order article via Infotrieve]
  13. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevazicumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006;113(3)363–372.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  14. Gaudreault J, Fei D, Rusit J, Suboc P, Shiu V. Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration. Invest Ophthalmol Vis Sci. 2005;46(2)726–733.[Abstract/Free Full Text]
  15. Heier JS, Antoszyk AN, Pavan PR, et al. Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. Ophthalmology. 2006;113(4)642.e1–e4.
  16. Rosenfeld PJ, Schwartz SD, Blumenkranz MS, et al. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology. 2005;112(6)1048–1053.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  17. Kim IK, Husain D, Michaud N, et al. Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid. Invest Ophthalmol Vis Sci. 2006;47(1)357–363.[Abstract/Free Full Text]
  18. Grossniklaus HE, Hutchinson AK, Capone A, Woolfson J, Lambert HM. Clinicopathologic features of surgically excised choroidal neovascular membranes. Ophthalmology. 1994;101(6)1099–1111.[Web of Science][Medline][Order article via Infotrieve]
  19. Lopez PE, Grossniklaus HE, Lambert HM, et al. Pathologic features of surgically excised neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1991;112(6)647–656.[Web of Science][Medline][Order article via Infotrieve]
  20. Gass JD. Biomicroscopic and histologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol. 1994;118(3)285–298.[Web of Science][Medline][Order article via Infotrieve]
  21. Thomas MA, Kaplan HJ. Surgical removal of subfoveal choroidal neovascularization in the presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 1991;111(1)1–7.[Web of Science][Medline][Order article via Infotrieve]
  22. Thomas MA, Dickinson JD, Melberg NS, Ibanez HE, Dhaliwal RS. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology. 1994;101(8)1384–1396.[Web of Science][Medline][Order article via Infotrieve]
  23. Eckstein M, Wells JA, Aylward GW, Gregor Z. Surgical removal of non-age-related subfoveal choroidal neovascular membranes. Eye. 1998;12(pt 5)775–780.[Web of Science][Medline][Order article via Infotrieve]
  24. Aisenbrey S, Lafaut BA, Szurman P, et al. Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol. 2002;120(4)451–459.[Abstract/Free Full Text]
  25. Cahill MT, Stinnett SS, Banks AD, Freedman SF, Toth CA. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration. Ophthalmology. 2005;112(1)144–151.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  26. Toth CA, Lapolice DJ, Banks AD, Stinnett SS. Improvement in near visual function after macular translocation surgery with 360-degree peripheral retinectomy. Graefes Arch Clin Exp Ophthalmol. 2004;242(7)541–548.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  27. Pieramici DJ, De Juan E, Jr, Fujii GY, et al. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol. 2000;130(4)419–428.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  28. Park CH, Toth CA. Macular translocation surgery with 360-degree peripheral retinectomy following ocular photodynamic therapy of choroidal neovascularization. Am J Ophthalmol. 2003;136(5)830–835.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  29. Akduman L, Karavellas MP, MacDonald JC, Olk RJ, Freeman WR. Macular translocation with retinotomy and retinal rotation for exudative age-related macular degeneration. Retina. 1999;19(5)418–423.[CrossRef][Medline][Order article via Infotrieve]
  30. Lewis H, Kaiser PK, Lewis S, Estafanous M. Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study. Am J Ophthalmol. 1999;128(2)135–146.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  31. Freedman SF, Holgado S, Enyedi LB, Toth CA. Management of ocular torsion and diplopia after macular translocation for age-related macular degeneration: prospective clinical study. Am J Ophthalmol. 2003;136(4)640–648.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  32. Abdel-Meguid A, Lappas A, Hartmann K, et al. One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol. 2003;87(5)615–621.[Abstract/Free Full Text]
  33. Fujii GY, Pieramici DJ, Humayun MS, et al. Complications associated with limited macular translocation. Am J Ophthalmol. 2000;130(6)751–762.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  34. Buffenn AN, de Juan E, Fujii G, Hunter DG. Diplopia after limited macular translocation surgery. J AAPOS. 2001;5(6)388–394.[Medline][Order article via Infotrieve]
  35. Schraermeyer U, Kociok N, Heimann K. Rescue effects of IPE transplants in RCS rats: short-term results. Invest Ophthalmol Vis Sci. 1999;40(7)1545–1556.[Abstract/Free Full Text]
  36. Geng L, Wihlmark U, Algvere PV. Lipofuscin accumulation in iris pigment epithelial cells exposed to photoreceptor outer segments. Exp Eye Res. 1999;69(5)539–546.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  37. Sakuragi M, Tomita H, Abe T, Tamai M. Changes of phagocytic capacity in basic fibroblast growth factor-transfected iris pigment epithelial cells in rats. Curr Eye Res. 2001;23(3)185–191.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  38. Dintelmann TS, Heimann K, Kayatz P, Schraermeyer U. Comparative study of ROS degradation by IPE and RPE cells in vitro. Graefes Arch Clin Exp Ophthalmol. 1999;237(10)830–839.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  39. Crafoord S, Geng L, Seregard S, Algvere PV. Photoreceptor survival in transplantation of autologous iris pigment epithelial cells to the subretinal space. Acta Ophthalmol Scand. 2002;80(4)387–394.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  40. Algvere PV, Gouras P, Dafgard Kopp E. Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD. Eur J Ophthalmol. 1999;9(3)217–230.[Web of Science][Medline][Order article via Infotrieve]
  41. Grisanti S, Ishioka M, Kosiewicz M, Jiang LQ. Immunity and immune privilege elicited by cultured retinal pigment epithelial cell transplants. Invest Ophthalmol Vis Sci. 1997;38(8)1619–1626.[Abstract/Free Full Text]
  42. Del Priore LV, Kaplan HJ, Tezel TH, Hayashi N, Berger AS, Green WR. Retinal pigment epithelial cell transplantation after subfoveal membranectomy in age-related macular degeneration: clinicopathologic correlation. Am J Ophthalmol. 2001;131(4)472–480.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  43. Weisz JM, Humayun MS, De-Juan E, Jr, et al. Allogenic fetal retinal pigment epithelial cell transplant in a patient with geographic atrophy. Retina. 1999;19(6)540–545.[CrossRef][Medline][Order article via Infotrieve]
  44. Zhang X, Bok D. Transplantation of retinal pigment epithelial cells and immune response in the subretinal space. Invest Ophthalmol Vis Sci. 1998;39(6)1021–1027.[Abstract/Free Full Text]
  45. Binder S, Stolba U, Krebs I, et al. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot study. Am J Ophthalmol. 2002;133(2)215–225.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  46. Binder S, Krebs I, Hilgers RD, et al. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci. 2004;45(11)4151–4160.[Abstract/Free Full Text]
  47. Van Meurs JC, ter Averst E, Hofland LJ, et al. Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br J Ophthalmol. 2004;88(1)110–113.[Abstract/Free Full Text]
  48. Phillips SJ, Sadda SR, Tso MO, Humayan MS, de Juan E, Binder S. Autologous transplantation of retinal pigment epithelium after mechanical debridement of Bruch’s membrane. Curr Eye Res. 2003;26(2)81–88.[Medline][Order article via Infotrieve]
  49. Peyman GA, Blinder KJ, Paris CL, Alturki W, Nelson NC, Jr, Desai U. A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surg. 1991;22(2)102–108.[Web of Science][Medline][Order article via Infotrieve]
  50. Stanga PE, Kychenthal A, Fitzke FW, et al. Retinal pigment epithelium translocation and central visual function in age related macular degeneration: preliminary results. Int Ophthalmol. 2001;23(4–6)297–307.[CrossRef][Medline][Order article via Infotrieve]
  51. Stanga PE, Kychenthal A, Fitzke FW, et al. Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration. Ophthalmology. 2002;109(8)1492–1498.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  52. Van Meurs JC, van Den Biesen PR. Autologous retinal pigment epithelium and choroids translocation in patients with exudative age-related macular degeneration: short-term follow-up. Am J Ophthalmol. 2003;136(4)688–695.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  53. Joussen AM, Heussen FM, Joeres S, et al. Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol. 2006;142(1)17–30.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  54. Joussen AM, Joeres S, Fawzy N, et al. Autologous translocation of the choroid and retinal pigment epithelium in patients with geographic atrophy. Ophthalmology. 2007;114(3)551–560.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  55. Treumer F, Bunse A, Klatt C, Roider J. Autologous retinal pigment epithelium-choroid sheet transplantation in age related macular degeneration: morphological and functional results. Br J Ophthalmol. 2007;91(3)349–353.[Abstract/Free Full Text]
  56. MacLaren RE, Uppal GS, Balaggan KS, et al. Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration. Ophthalmology. 2007;114(3)561–570.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  57. MacLaren RE, Bird AC, Sathia PJ, Aylward GW. Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration. Ophthalmology. 2005;112(12)2081–2087.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  58. Yepez JB, Arevalo JF. RPE translocation in ARMD. Ophthalmology. 2003;110(11)2262.[Web of Science][Medline][Order article via Infotrieve]
  59. Stanzel BV, Espana EM, Grueterich M, et al. Amniotic membrane maintains the phenotype of rabbit retinal pigment epithelial cells in culture. Exp Eye Res. 2005;80(1)103–112.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  60. Ohno Matsui K, Ichinose S, Nakahama K, et al. The effects of amniotic membrane on retinal pigment epithelial cell differentiation. Mol Vis. 2005;11:1–10.[Web of Science][Medline][Order article via Infotrieve]
  61. Thumann G, Schraermeyer U, Bartz Schmidt KU, Heimann K. Descemet’s membrane as membranous support in RPE/IPE transplantation. Curr Eye Res. 1997;16(12)1236–1238.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  62. Hartmann U, Sistani F, Steinhorst UH. Human and porcine anterior lens capsule as support for growing and grafting retinal pigment epithelium and iris pigment epithelium. Graefes Arch Clin Exp Ophthalmol. 1999;237(11)940–945.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  63. Nicolini J, Kiilgaard JF, Wiencke AK, et al. The anterior lens capsule used as support material in RPE cell-transplantation. Acta Ophthalmol Scand. 2000;78(5)527–531.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  64. Lu L, Yaszemski MJ, Mikos AG. Retinal pigment epithelium engineering using synthetic biodegradable polymers. Biomaterials. 2001;22(24)3345–3355.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  65. Hadlock T, Singh S, Vacanti JP, McLaughlin BJ. Ocular cell monolayers cultured on biodegradable substrates. Tissue Eng. 1999;5(3)187–196.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  66. Thomson RC, Giordano GG, Collier JH, et al. Manufacture and characterization of poly(alpha-hydroxy ester) thin films as temporary substrates for retinal pigment epithelium cells. Biomaterials. 1996;17(3)321–327.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  67. Wang H, Yagi F, Cheewatrakoolpong N, Sugino IK, Zarbin MA. Short-term study of retinal pigment epithelium sheet transplants onto Bruch’s membrane. Exp Eye Res. 2004;78(1)53–65.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  68. Maaijwee KJ, van Meurs JC, Kirchhof B, et al. Histological evidence for revascularisation of an autologous retinal pigment epithelium-choroid graft in the pig. Br J Ophthalmol. 2007;91(4)546–550.[Abstract/Free Full Text]
  69. McKeever PJ, Braden TD. Comparison of full- and partial-thickness autogenous skin transplantation in dogs: a pilot study. Am J Vet Res. 1978;39(10)1706–1709.[Web of Science][Medline][Order article via Infotrieve]
  70. Holz FG, Bindewald A, Schutt F, Specht H. Intraocular microablation of choroidal tissue by a 308 nm AIDA excimer laser for RPE-transplantation in patients with age-related macular degeneration. Biomed Tech (Berl). 2003;48(4)82–85.[Medline][Order article via Infotrieve]
  71. Saari JC, Bredberg L, Garwin GG. Identification of the endogenous retinoids associated with three cellular retinoid-binding proteins from bovine retina and retinal pigment epithelium. J Biol Chem. 1982;257(22)13329–13333.[Abstract/Free Full Text]
  72. Saari JC, Nawrot M, Kennedy BN, et al. Visual cycle impairment in cellular retinaldehyde binding protein (CRALBP) knockout mice results in delayed dark adaptation. Neuron. 2001;29(3)739–748.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  73. Bunt-Milam AH, Saari JC. Immunocytochemical localization of two retinoid-binding proteins in vertebrate retina. J Cell Biol. 1983;97(3)703–712.[Abstract/Free Full Text]
  74. Campochiaro PA, Hackett SF. Corneal endothelial cell matrix promotes expression of differentiated features of retinal pigmented epithelial cells: implication of laminin and basic fibroblast growth factor as active components. Exp Eye Res. 1993;57(5)539–547.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  75. Daeman FJ. Veretebrate rod outer segment membranes. Biochim Biophys Acta. 1973;300(3)255–288.[Medline][Order article via Infotrieve]
  76. Ostroy SE. Rhodopsin and the visual process. Biochim Biophys Acta. 1977;463(1)91–125.[Medline][Order article via Infotrieve]
  77. Heitzmann H. Rhodopsin is the predominant protein of rod outer segment membranes. Nat New Biol. 1972;235(56)114.[Web of Science][Medline][Order article via Infotrieve]
  78. Hagins WA. The visual process: excitatory mechanisms in the primary receptor cells. Annu Rev Biophys Bioeng. 1972;1:131–158.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  79. Gupta BD, Goyal IC, Ghatak AK. Flash photolysis of rhodopsin in rabbit. Biophys Struct Mech. 1978;4(2)129–138.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  80. Ripps H, Weale RA. Flash bleaching of rhodopsin in the human retina. J Physiol. 1969;200(1)151–159.[Abstract/Free Full Text]
  81. Grignolo A, Orzalesi N, Calabria GA. Studies on the fine structure and the rhodopsin cycle of the rabbit retina in experimental degeneration induced by sodium iodate. Exp Eye Res. 1966;5(1)86–97.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  82. Bergstrom A, Ehinger B, Wilke K, Zucker CL, Adolph AR, Szel A. Development of cell markers in subretinal rabbit retinal transplants. Exp Eye Res. 1994;58(3)301–313.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  83. Aramant R, Seiler MJ. Transplanted sheets of human retina and retinal pigment epithelium develop normally in nude rats. Exp Eye Res. 2002;75(2)115–125.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  84. Davis FA. The anatomy and histology of the eye and orbit of the rabbit. Trans Am Ophthal Soc. 1929;27:401–441.
  85. Del Priore LV, Kaplan HJ, Hornbeck R, Jones Z, Swinn M. Retinal pigment epithelial debridement as a model for the pathogenesis and treatment of macular degeneration. Am J Ophthalmol. 1996;122(5)629–643.[Web of Science][Medline][Order article via Infotrieve]
  86. Leonard DS, Zhang X, Panozzo G, Sugino IK, Zarbin MA. Clinicopathological correlation of localized retinal pigment epithelium debridement. Invest Ophthalmol Vis Sci. 1997;38(6)1094–1109.[Abstract/Free Full Text]
  87. Ivert L, Kong J, Gouras P. Changes in the choroidal circulation of rabbit following RPE removal. Greafe’s Arch Clin Exp Ophthalmol. 2003;241(8)656–666.[CrossRef]
  88. Grunwald JE, Hariprasad SM, DuPont J. Effect of aging on foveolar choroidal circulation. Arch Ophthalmol. 1998;116(2)150–154.[Abstract/Free Full Text]
  89. Grunwald JE, Hariprasad SM, DuPont J, et al. Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1998;39(2)385–390.[Abstract/Free Full Text]
  90. Pauleikhoff D, Spital G, Radermacher M, Brumm GA, Lommatzsch A, Bird AC. A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. Arch Ophthalmol. 1999;117(10)1353–1358.[Abstract/Free Full Text]
  91. Spraul CW, Lang GE, Grossniklaus HE. Morphometric analysis of the choroid, Bruch’s membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37(13)2724–2735.[Abstract/Free Full Text]
  92. Harris A, Chung HS, Ciulla TA, Kagemann L. Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration. Prog Retin Eye Res. 1999;18(5)669–687.[CrossRef][Web of Science][Medline][Order article via Infotrieve]



This article has been cited by other articles:


Home page
 Br. J. Ophthalmol.Home page
T U Krohne, S Hunt, and F G Holz
Effect of 308 nm excimer laser irradiation on retinal pigment epithelium cell viability in vitro
Br. J. Ophthalmol., January 1, 2009; 93(1): 91 - 95.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
iovs.07-1299v1
49/7/3185    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, Y.
Right arrow Articles by Ma, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, Y.
Right arrow Articles by Ma, Z.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS